Starting at $1,249.99 /mo *Maximus clinical study data on Maximus clients Proprietary formula, powerful outcomes
Target Consumer Segments Adults With Weight Management Goals (2550) : men and women seeking therapeutic supplementation for appetite regulation, fat metabolism, and sustainable weight loss Adults With Pre-diabetes Or Type 2 Diabetes (3060) : individuals requiring preventative and therapeutic support for blood sugar control and improved insulin sensitivity Obese And Overweight Consumers (2555) : adults addressing obesity-related health risks who benefit from GLP-1 booster supplementation for metabolic balance Seniors (55+) : older adults managing slower metabolism and cardiovascular health who require preventative supplementation for healthy aging and weight control Fitness Enthusiasts (2040) : active adults and athletes seeking appetite management, sustained energy, and recovery benefits from GLP-1 support Patients In Recovery : individuals overcoming chronic metabolic disorders or post-treatment fatigue who benefit from therapeutic supplementation for stabilization and resilience Regional Consumer Demand North America Market Insight : North America has a rapidly growing market for weight management and blood sugar control supplements, with a focus on natural, clinically-supported products
Weight plateaus can be addressed through dose escalation (if tolerated), lifestyle intensification, or strategic medication adjustments in consultation with your provider
Read more How to Maximize Results After Switching GLP1 Medications Uncategorized Switching GLP1 medications can feel like a fresh start
Epigallocatechin-3-gallate protects against the exacerbation of allergic eosinophilic inflammation associated with obesity in mice
Superiority of a vitamin B(12)-containing emollient compared to a standard emollient in the maintenance treatment of mild-to-moderate plaque psoriasis
